Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer

Integrative Cancer Therapies
Anthony J BazzanDaniel A Monti

Abstract

Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA. The purpose of this study was to expand the current literature using a retrospective analysis of adverse events and symptomatic changes of IV AA in a large sample of cancer patients. We conducted a retrospective chart review of all patients receiving IV AA for cancer at the Thomas Jefferson University Hospital over a 7-year period. We assessed all reports of adverse events, laboratory findings, and hospital or emergency department admissions. We also reviewed quality-of-life data, including fatigue, nausea, pain, appetite, and mood. There were 86 patients who received a total of 3034 doses of IV AA ranging from 50 to 150g. In all, 32 patients received only ascorbic acid as part of their cancer management (1197 doses), whereas 54 patients received ascorbic acid in conjunction with chemotherapy (1837 doses). The most common adverse events related to ascorbic acid were temporary nausea and discomfort at the injection site. All events reported in the ascorbic acid alone group were associated with less than 3% of the total number of infusions. Pati...Continue Reading

References

Jan 1, 1985·Cardiovascular and Interventional Radiology·J E Dacie, J S Lumley
May 1, 1985·Archives of Internal Medicine·J M LawtonP A Abraham
Aug 1, 1994·Australian and New Zealand Journal of Medicine·K WongJ Gardner
Jan 1, 1997·Annals of Nutrition & Metabolism·H Gerster
Apr 8, 2004·Annals of Internal Medicine·Sebastian J PadayattyMark Levine
Jul 1, 2005·The Journal of Nutrition·Linda K MasseySusan A Kynast-Gales
Sep 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Qi ChenMark Levine
Jun 12, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L J HofferW H Miller
Aug 22, 2008·Anaesthesia and Intensive Care·G J McHughR C Freebairn
Jan 22, 2009·Metabolism: Clinical and Experimental·Line RobitailleL John Hoffer
Feb 6, 2013·JAMA Internal Medicine·Laura D K ThomasAgneta Akesson
May 29, 2014·Integrative Cancer Therapies·Heidi FritzDugald Seely
Sep 16, 2014·Basic & Clinical Pharmacology & Toxicology·Torben K NielsenKári J Mikines
Oct 16, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Pietro Manuel FerraroEric N Taylor
Sep 29, 2017·Blood Cells, Molecules & Diseases·Domenico MastrangeloUgo Testa

❮ Previous
Next ❯

Methods Mentioned

BETA
fluid collection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.